Alicia Secor (Atalanta)

Genen­tech and Bio­gen roll the dice on an up­start biotech with a new siR­NA ap­proach — go­ing deep in­to the brain for tar­gets in neu­rode­gen­er­a­tion

Ata­lan­ta isn’t your av­er­age stealth biotech mak­ing a de­but. They have some his­to­ry and deals to sketch out in rough out­lines.

The found­ing ex­ecs date …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.